RxDoctor Payments Data

Kenneth Bowman

Physician Assistant · Ripon, CANPI 1144478801

Payments from drug & device makers

$3,820in general payments, 2019–2025

Across 215 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$757
  • Amgen$377
  • Lilly USA, LLC$278
  • Boehringer Ingelheim$250
  • GSK$218
  • AbbVie$207
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$3,820100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,820 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$35,590
Medicare patients
190
Services billed
687

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$57,297
FarxigaDapagliflozin Propanediol11$16,391
MounjaroTirzepatide13$13,765
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$1,145
Atorvastatin Calcium78$1,126
Levothyroxine Sodium61$979
Testosterone Cypionate13$916
Losartan Potassium74$806
Lisinopril72$711
Gabapentin42$659
Rosuvastatin Calcium29$633
Alprazolam69$592
Metformin Hcl44$559
Escitalopram Oxalate31$468
Pantoprazole Sodium40$437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$164$57,29753 claims
AstraZenecaFarxiga$757$16,39111 claims
Lilly USA, LLCMounjaro$278$13,76513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Ripon

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →